biotech

ETF Trends

Biotech ETFs are at a Crucial Technical Juncture

By Tom LydonJuly 18, 2016

Brexit: A Bane for Bumbling Biotech ETFs?

Brexit: A Bane for Bumbling Biotech ETFs?

By Tom LydonJune 28, 2016

A Technical Test For A Big Biotech ETF

A Technical Test For A Big Biotech ETF

By Tom LydonMay 26, 2016

Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs

Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs

By Max ChenMay 16, 2016

Resisting the Temptation of Biotech ETFs

Resisting the Temptation of Biotech ETFs

By Brenton GarenMay 16, 2016

A Biotechnology ETF Proving Immune to Hawkish Fed Policy Changes

A Biotech ETF Proving Immune to Hawkish Fed Policy Changes

By Brenton GarenMay 4, 2016

Hit The Lab With These 17 Biotech ETFs

Hit The Lab With These 17 Biotech ETFs

By Tom LydonMay 2, 2016

Alternative ETFs

Traders Capitalize on Biotech Rebound with Leveraged ETFs

Capitalizing on the Biotech Rebound with Leveraged ETFs

By Max ChenApril 18, 2016

Believing in the Biotech ETF Bounce

Believing in the Biotech ETF Bounce

By Tom LydonApril 13, 2016

Silver Lining for Biotechnology ETFs After Pfizer Calls off Deal with Allergan

Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal

By Max ChenApril 6, 2016

More Good Technical News for Biotech ETFs

More Good Technical News for Biotech ETFs

By Brenton GarenApril 5, 2016

ETF Trends

Pharmacyclics Takeover Shines a Light on a new Biotech ETF

By Todd ShriberMarch 5, 2015

ETF Trends

QQQ Faces Important Tests

By Todd ShriberJuly 22, 2014